(ZZ-B) Zinzino Series - Ratings and Ratios
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0002480442
ZZ-B: Skincare Products, Dietary Supplements, Coffee, Health Tests
Zinzino AB (publ), a Swedish direct sales company, specializes in health and wellness products, including dietary supplements and skincare. Operating through segments Zinzino and Faun, the company offers skincare products such as cleansers and serums, and dietary supplements for immune support, gut health, and weight management. Additionally, Zinzino sells coffee products and home health tests, leveraging an online distribution model. Founded in 2005, the company has expanded its presence internationally, focusing on a network of independent partners for product distribution. Their commitment to innovation and wellness is reflected in their product range, which includes recent launches aimed at modern health trends.
Over the next three months, Zinzinos stock (ST:ZZ-B) is expected to show continued strength. The stocks price of 165.00 SEK, coupled with its SMA20 at 149.45 and SMA50 at 144.70, suggests a bullish trend, with the stock trading above these moving averages. The SMA200 at 102.70 further indicates long-term growth potential. The ATR of 6.90 signals moderate volatility, offering manageable risk for investors. Fundamentally, the companys high P/E of 33.09 and P/B of 13.73 reflect market confidence in future growth, supported by an impressive RoE of 43.81%. While the absence of forward P/E data leaves some uncertainty, the companys strong financials and product expansion suggest sustained growth, though investors should monitor if earnings match the high valuation expectations.
Additional Sources for ZZ-B Stock
ZZ-B Stock Overview
Market Cap in USD | 548m |
Sector | Consumer Defensive |
Industry | Packaged Foods |
GiC Sub-Industry | Packaged Foods & Meats |
IPO / Inception |
ZZ-B Stock Ratings
Growth Rating | 77.0 |
Fundamental | 80.6 |
Dividend Rating | 78.2 |
Rel. Strength | 116 |
Analysts | - |
Fair Price Momentum | 202.57 SEK |
Fair Price DCF | 218.18 SEK |
ZZ-B Dividends
Dividend Yield 12m | 2.33% |
Yield on Cost 5y | 12.14% |
Annual Growth 5y | 40.40% |
Payout Consistency | 97.8% |
ZZ-B Growth Ratios
Growth Correlation 3m | 81.8% |
Growth Correlation 12m | 92.3% |
Growth Correlation 5y | 51.2% |
CAGR 5y | 46.92% |
CAGR/Max DD 5y | 0.67 |
Sharpe Ratio 12m | 2.40 |
Alpha | 136.50 |
Beta | 0.363 |
Volatility | 54.44% |
Current Volume | 65.4k |
Average Volume 20d | 52.6k |
As of May 01, 2025, the stock is trading at SEK 170.20 with a total of 65,380 shares traded.
Over the past week, the price has changed by +3.65%, over one month by +18.85%, over three months by +52.24% and over the past year by +140.19%.
Yes, based on ValueRay Fundamental Analyses, Zinzino Series (ST:ZZ-B) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 80.63 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ZZ-B as of May 2025 is 202.57. This means that ZZ-B is currently undervalued and has a potential upside of +19.02% (Margin of Safety).
Zinzino Series has no consensus analysts rating.
According to ValueRays Forecast Model, ZZ-B Zinzino Series will be worth about 222.8 in May 2026. The stock is currently trading at 170.20. This means that the stock has a potential upside of +30.91%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 134 | -21.3% |
Analysts Target Price | - | - |
ValueRay Target Price | 222.8 | 30.9% |